Insmed Reports Second Quarter 2022 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Insmed (INSM) Tops Q2 EPS by 9c
August 4, 2022 7:35 AM EDTInsmed (NASDAQ: INSM) reported Q2 EPS of ($0.80), $0.09 better than the analyst estimate of ($0.89). Revenue for the quarter came in at $65.2 million versus the consensus estimate of $58.79 million.
As of June 30, 2022, Insmed had cash and cash equivalents and marketable securities of $564.6 million. The... More
